Nutritional support of the cancer patient: Issues and dilemmas

Critical Reviews in Oncology/Hematology

Volumn 34, Issue 3, 2000, Pages 137-168

  Nitenberg, Gérard ^a,b   Raynard, Bruno ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Board of Trustees   (United States)

Author keywords

Appetite stimulants; Arginine; Cachexia; Enteral nutrition; Glutamine; Immunology prevention and control; Neoplasms; Nutritional status; Nutritional support; Omega 3 fatty acids; Total parenteral nutrition

Indexed keywords

ELECTROLYTE; GLUCOSE; GLUTAMINE; LIPID; NITROGEN; TRACE ELEMENT; VITAMIN;

CANCER PALLIATIVE THERAPY; CANCER PATIENT; COST BENEFIT ANALYSIS; ENTERIC FEEDING; GASTROINTESTINAL TOXICITY; HUMAN; MALNUTRITION; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PATIENT COUNSELING; QUALITY OF LIFE; REVIEW;

CACHEXIA; DIETARY SUPPLEMENTS; FEEDING BEHAVIOR; HUMANS; NEOPLASMS; NUTRITION ASSESSMENT; NUTRITION DISORDERS; NUTRITIONAL SUPPORT;

EID: 0034035869     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(00)00048-2     Document Type: Review

References (238)

1. Ottery FD. Supportive nutrition to prevent cachexia and improve quality of life. Semin Oncol 1995;22(2 Suppl. 3):98-111.
2. Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients: Eastern Cooperative Oncology Group. Am J Med 1980;69(4):491-7.
3. Abitbol JL, Nitenberg G, Fuerxer F, et al. Effects of varying intake of total parenteral nutrition in bone marrow transplant recipients: a randomized prospective trial (abstract). Clin Nutr 1989;8:70a.
4. Delbecque-Boussard L, Gottrand F, Ategbo S, et al. Nutritional status of children with acute lymphoblastic leukemia: a longitudinal study. Am J Clin Nutr 1997;65(1):95-100.
5. Uderzo C, Rovelli A, Bonomi M, et al. Nutritional status in untreated children with acute leukemia as compared with children without malignancy. J Pediatr Gastroenterol Nutr 1996;23(1):34-7.
6. Edington J, Kon P, Martyn C. Prevalence of malnutrition in patients in general practice. Clin Nutr 1996;15:60-3.
7. Tchekmedyian NS. Costs and benefits of nutrition support in cancer. Oncology 1995;9(11):79-84.
8. Naber T, Schermer T, de Bree A, et al. Prevalence of malnutrition in nonsurgical hospitalized patients and its association with disease complications. Am J Clin Nutr 1997;66(5):1232-9.
9. Reilly J, Hull S, Albert N, et al. Economic impact of malnutrition: a model system for hospitalized patients. J Parenter Enteral Nutr 1988;12:371-6.
10. Laviano A, Meguid MM. Nutritional issues in cancer management. Nutrition 1996;12(5):358-71.
11. McWhirter J, Pennington C. Incidence and recognition of malnutrition in hospital. Br Med J 1994;9(308 (6934):945-8.
12. Laviano A, Renvyle T, Yang ZJ. From laboratory to bedside: new strategies in the treatment of malnutrition in cancer patients. Nutrition 1996;12(2):112-22.
13. Heber D, Tchekmedyian N. Cancer cachexia and anorexia. In: Heber D, Blackburn GL, Go VLW, editors. Nutritional Oncology. San Diego: Academic Press, 1999:537-46.
14. Nitenberg G, Raynard B, Antoun S. Physiopathologie de la cachexie cancéreuse. In: Leverve X, Cosnes J, Erny P, Hasselmann M, editors. Traité de nutrition artificielle de l'adulte. Paris: Mariette Guéna, 1998:665-71.
15. De Blauw I, Deutz N, Von Meyenfeldt M. Metabolic changes in cancer cachexia-first of two parts. Clin Nutr 1997;16:169-76.
16. Tisdale MJ. Cancer cachexia: metabolic alterations and clinical manifestations. Nutrition 1997;13(1):1-7.
17. Argiles JM, Alvarez B, Lopez-Soriano FJ. The metabolic basis of cancer cachexia. Med Res Rev 1997;17(5):477-98.
18. Gough DB, Heys SD, Eremin O. Cancer cachexia: pathophysiological mechanisms. Eur J Surg Oncol 1996;22(2):192-6.
19. Albrecht JT, Canada TW. Cachexia and anorexia in malignancy. Hematol-Oncol Clin North Am 1996;10(4):791-800.
20. Shike M. Nutrition therapy for the cancer patient. Hematol-Oncol Clin North Am 1996;10(1):221-34.
21. Toomey D, Redmond HP, Bouchier-Hayes D. Mechanisms mediating cancer cachexia. Cancer 1995;76(12):2418-26.
22. Norton JA, Peacock JL, Morrison SD. Cancer cachexia. Crit Rev Oncol Hematol 1987;7:289-327.
23. Bruera E. Clinical management of anorexia and cachexia in patients with advanced cancer. Oncology 1992;2(35):35-42.
24. DeWys WD. Anorexia as a general effect of cancer. Cancer 1979;43:2013-9.
25. DeWys WD. Abnormalities of taste sensations in cancer patients. Cancer 1975;36:1888-96.
26. Bennegard K, Lundgren F, Lundholm K. Mechanisms of insulin resistance in cancer associated malnutrition. Clin Physiol 1986;6(6):539-47.
27. Burt ME, Aoki TT, Gorschboth CM, Brennan MF. Peripheral tissue metabolism in cancer-bearing man. Ann Surg 1983;198:685-91.
28. Daly JM, Hoffman K, Lieberman M, et al. Nutritional support in the cancer patient, Jpn J Parenter Enteral Nutr 1990;14:244-248S.
29. Puccio M, Nathanson L. The cancer cachexia syndrome. Semin Oncol 1997;24(3):277-87.
30. Mitchell EP. Gastrointestinal toxicity of chemotherapeutic agents. Semin Oncol 1992;19(5):566-79.
31. Rodier JF. Radiation enteropathy - incidence, aetiology, risk factors, pathology and symptoms. Tumori 1995;81(3):122-5.
32. Letschert JG. The prevention of radiation-induced small bowel complications, Eur. J. Cancer 1995;31A:1361-1365.
33. Le Bricon T, Cynober L, Baracos VE. Ornithine alpha-ketoglutarate limits muscle protein breakdown without stimulating tumor growth in rats bearing Yoshida ascites hepatoma. Metab Clin Exp 1994;43(7):899-905.
34. Lazarus DD, Kambayashi T, Lowry S, Strassmann G. The lack of an effect by insulin or insulin-like growth factor-1 in attenuating colon-2-mediated cancer cachexia. Cancer Lett 1996;103(1):71-7.
35. Nixon DW, Kutner M, Heymsfield S, et al. Resting energy expenditure in lung and colon cancer. Metabolism 1988;37(11):1059-64.
36. Hyltander A, Warnold I, Eden E, Lundholm K. Effect on whole-body protein synthesis after institution of intravenous nutrition in cancer and non-cancer patients who lose weight. Eur J Cancer 1991;27(1):16-21.
37. Falconer JS, Fearon KC, Plester CE, Ross JA, Carter DC. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 1994;219(4):325-31.
38. Rising R. Resting energy expenditure in cancer patients. J Am Coll Nutr 1995;14(5):409-10.
39. Delarue J, Lerebours E. Statut métabolique et nutritionnel des cancéreux. Gastroenterol Clin Biol 1987;11:558-64.
40. Fredrix EW, Soeters PB, Wouters EF, Deerenberg IM, von Meyenfeldt MF, Saris WH. Effect of different tumor types on resting energy expenditure. Cancer Res 1991;51(22):6138-41.
41. Hansell DT, Davies JWL, Burns HJG. The relashioship between resting energy expenditure and weight loss in benign and malignant disease. Ann Surg 1986;203:240-5.
42. Knox LS, Crosby LO, Feurer ID, Buzby GP, Miller CL, Mullen JL. Energy expenditure in malnourished cancer patients. Ann Surg 1983;197:152-62.
43. Hyltander A, Korner U, Lundholm KG. Evaluation of mechanisms behind elevated energy expenditure in cancer patients with solid tumours. Eur J Clin Invest 1993;23(1):46-52.
44. Staal-van den Brekel A, Dentener M, Schols A, Buurman W, Wouters E. Increased energy expenditure and weight loss are related to a sytstemic inflammatory response in lung cancer patients. J Clin Oncol 1995;13:2600-5.
45. Humberstone DA, Shaw JH. Metabolism in hematologic malignancy. Cancer 1988;62(8):1619-24.
46. Tisdale MJ. Cancer cachexia. Anti Cancer Drugs 1993;4(2):115-25.
47. Tayek JA. A review of cancer cachexia and abnormal glucose metabolism in humans with cancer. J Am Col Nutr 1992;11:445-56.
48. Rofe AM, Bourgeois CS, Coyle P, Taylor A, Abdi EA. Altered insulin response to glucose in weight-losing cancer patients. Anticancer Res 1994;14(2B):647-50.
49. Keller U. Pathophysiology of cancer cachexia. Support Care Cancer 1993;1(6):290-4.
50. Shaw JHF, Wolfe RR. Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. Ann Surg 1987;205:368-76.
51. Smith KL, Tisdale MJ. Mechanism of muscle protein degradation in cancer cachexia. Br J Cancer 1993;68(2):314-8.
52. Norton JA, Gorschboth CM, Wesley RA, Burt ME, Brennan MF. Fasting plasma amino acid levels in cancer patients. Cancer 1985;56:1181-6.
53. Pearlstone DB, Lee JI, Alexander RH, Chang TH, Brennan MF, Burt M. Effect of enteral and parenteral nutrition on amino acid levels in cancer patients. J Parenter Enteral Nutr 1995;19(3):204-8.
54. Droge W, Gross A, Hack V, et al. Role of cysteine and glutathione in HIV infection and cancer cachexia: therapeutic intervention with N-acetylcysteine. Adv Pharmacol 1997;38:581-600.
55. Pisters PW, Pearlstone DB. Protein and amino acid metabolism in cancer cachexia: investigative techniques and therapeutic interventions. Crit Rev Clin Lab Sci 1993;30(3):223-72.
56. Lundholm K, Bennegard K, Eden E, Svaninger G, Emery PW, Rennie MJ. Efflux of 3-methylhistidine from the leg in cancer patients who experience weight loss. Cancer Res 1982;42(11):4807-11.
57. Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ, Argiles JM. Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis. Intern J Cancer 1995;61(1):138-41.
58. Jeevanandam M, Lowry SF, Horowitz GD, Brennan MF. Cancer cachexia and protein metabolism. Lancet 1984;2:1423-6.
59. Anonymous. Proceedings of an international symposium on cancer, cachexia, cytokines, and EPA: nutritional applications. Charleston, South Carolina, December 2-4, 1995. Nutrition 1996;12(1): S1-65.
60. Plata-Salaman CR. Cytokine-induced anorexia: behavioral, cellular, and molecular mechanisms. Ann NY Acad Sci 1998;856:160-70.
61. Gough DB, Heys SD, Eremin O. II-Cancer cachexia: treatments strategies. Eur J Surg Oncol 1996;22(3):286-92.
62. Lundholm K, Gelin J, Hyltander A, et al. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res 1994;54(21):5602-6.
63. Todorov P, Cariuk P, McDevitt T, Coles B, Fearon K, Tisdale M. Characterization of a cancer cachectic factor. Nature 1996;379(6567):739-42.
64. Cariuk P, Lorite MJ, Todorov PT, Field WN, Wigmore SJ, Tisdale MJ. Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients. Br J Cancer 1997;76(5):606-13.
65. Tisdale MJ, McDevitt TM, Todorov PT, Cariuk P. Catabolic factors in cancer cachexia. In Vivo 1996;10(2):131-6.
66. Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999;130(8):671-80.
67. Bozzetti F, Gavazzi C, Mariani L, Crippa F. Artificial nutrition in cancer patients: which route, what composition? World J Surg 1999;23(6):577-83.
68. Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC, Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer 1998;82(2):395-402.
69. Chlebowski RT, Palomares MR, Lillington L, Grosvenor M. Recent implications of weight loss in lung cancer management. Nutrition 1996;12(1):S43-7.
70. Grindel CG, Whitmer K, Barsevick A. Quality of life and nutritional support in patients with cancer. Cancer Pract 1996;4(2):81-7.
71. Delmore G. Assessment of nutritional status in cancer patients: widely neglected? Support Care Cancer 1997;5(5):376-80.
72. Baker JP, Detsky AS, Wesson DE, et al. Nutritional assessment: a comparison of clinical judgement and objective measurements. N Engl J Med 1982;306(16):969-72.
73. Ottery FD. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 1996;12(1):S15-9.
74. Detsky AS, McLaughlin JR, Baker JP, et al. What is subjective global assessment of nutritional status? J Parenter Enteral Nutr 1987;11(1):8-13.
75. Reilly JJ, Wilson J, Durnin JV. Determination of body composition from skinfold thickness: a validation study. Arch Dis Child 1995;73(4):305-10.
76. Poisson-Salomon AVC, Sermet I, et al. Prise en charge du risque nutritionnel: vers une amélioration des pratiques. Nutr Clin Métabol 1997;11:161-8.
77. Thorsdottir I, Eriksen B, Eysteinsdottir S. Nutritonal status at submission for dietetic services and screening for malnutrition at admission to hospital. Clin Nutr 1999;18:15-21.
78. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974;32(1):77-97.
79. Constans T, Bacq Y, Bertrand P, et al. The american anthropometric norms are not suitable to assess the nutritional status of a French population. J Clin Nutr 1990;9(3):163-7.
80. Hall J, O'Quigley J, Giles G, Appleton N, Stocks H. Upper limb anthropometry: the value of measurement variance studies. Am J Clin Nutr 1980;33:1846-51.
81. Inoue Y, Nezu R, Matsuda H, Takagi Y, Okada A. Rapid turnover proteins as a prognostic indicator in cancer patients. Surg Today 1995;25(6):498-506.
82. Vitello J. Nutritional assessment and the role of preoperative parenteral nutrition in the colon cancer patient. Semin Surg Oncol 1994;10:183-94.
83. Ingenbleek Y, Carpentier YA. A prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vitam Nutr Res 1985;55(1):91-101.
84. Donahue SP, Phillips LS. Response of IGF-1 to nutritional support in malnourished hospital patients: a possible indicator of short-term changes in nutritional status. Am J Clin Nutr 1989;50(5):962-9.
85. Kalfarentzos F, Spiliotis J, Velimezis G, Dougenis D, Androulakis J. Comparison of forearm muscle dynamometry with nutritional prognostic index, as a preoperative indicator in cancer patients. J Parenter Enteral Nutr 1989;13(1):34-6.
86. Simons JP, Schols AM, Westerterp KR, ten Velde GP, Wouters EF. The use of bioelectrical impedance analysis to predict total body water in patients with cancer cachexia. Am J Clin Nutr 1995;61(4):741-5.
87. Fredrix EW, Saris WH, Soeters PB, et al. Estimation of body composition by bioelectrical impedance in cancer patients. Eur J Clin Nutr 1990;44(10):749-52.
88. Desport J, Courat L, Preux P, et al. Etude des malnutritions de l'adulte avec et sans oedèmes dépistés lors de la consultation de nutrition d'un hôpital universitaire. Nutr Clin Métabol 1999;13:25-34.
89. Ottery FD. Rethinking nutritional support of the cancer patient: the new field of nutritional oncology. Semin Oncol 1994;21(6):770-8.
90. Boock C, Reddick J. Taste alterations in bone marrow transplant patients. J Am Diet Assoc 1991;91:1121-2.
91. Ripamonti C, Zecca ECB, et al. A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer 1998;82:1938-45.
92. Mattson T, Arvidson K, Heimdahl A, et al. Alterations in taste acuity associated with allogeneic bone marrow transplantation. J Oral Pathol Med 1999;21:33-7.
93. Ovesen L, Allingstrup L, Hannibal J, et al. Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol 1995;11:2043-9.
94. Bachmann P, Gordiani B, Ranchere J, et al. Evaluation de l'indication et de la qualité de la prise en charge nutritionnelle en cancérologie médicale. Nutr Clin Métabol 1998;12:3-11.
95. Potter J, Langhorne P, Roberts M. Routine protein energy supplementation in adults: systematic review. Br Med J 1998;317(7157):495-501.
96. Gianotti L, Braga M, Vignali A, et al. Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms. Arch Surg 1997;132(11):1222-9.
97. McCarter MD, Gentilini OD, Gomez ME, Daly JM. Preoperative oral supplement with immunonutrients in cancer patients. J Parenter Enteral Nutr 1998;22(4):206-11.
98. Bruera E. Pharmacological treatment of cachexia: any progress? Support Care Cancer 1998;6(2):109-13.
99. Herrington A, Herrington J, Church C. Pharmacological options for the treatment of cachexia. Nutr Clin Pract 1997;12:101-13.
100. Kurebayashi J, Yamamoto S, Otsuki T, Sonoo H. Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect. Br J Cancer 1999;79(3-4):631-6.
101. Bruera E, Ernst S, Hagen N, et al. Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study. Cancer Prev Contr 1998;2(2):74-8.
102. McMillan D, Wigmore S, Fearon K, et al. A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Br J Cancer 1999;79:495-500.
103. Merrick H, Long C, Grecos G, Dennis R, Blakemore W. Energy requirements for total cancer patients and the effect of parenteral nutrition. J Parenter Enteral Nutr 1988;1:8.
104. Nitenberg G. Parenteral and enteral nutrition. In: Pinsky M, Dhainaut JE, editors. Pathophysiologic Foundations of Critical Care Medicine. Baltimore: William & Wilkins, 1993:42-81.
105. Grant J. Handbook of Total parenteral nutrition. Philadelphia: W.B. Saunders Cy, 1992. 1 Volume, 368 p.
106. Konstantinides FN. Nitrogen balance studies in clinical nutrition. Nutr Clin Pract 1992;7(5):231-8.
107. Geibig C, Ponting Owens J, Mirtallo J, et al. Parenteral nutrition for bone marrow transplant recipients: evaluation of an increase nitrogen dose. J Parenter Enteral Nutr 1991;15:184-8.
108. Leverve X, Guignier M, Carpentier F, Serre JC, Caravel JP. Effect of parenteral nutrition on muscle amino acid output and 3-methylhistidine excretion in septic patients. Metabolism 1984;33(5):471-7.
109. Shaw JH. Influence of stress, depletion, and/or malignant disease on the responsiveness of surgical patients to total parenteral nutrition. Am J Clin Nutr 1988;48(1):144-7.
110. McNurlan MA, Heys SD, Park KG, et al. Tumour and host tissue responses to branched-chain amino acid supplementation of patients with cancer. Clin Sci (Colch) 1994;86(3):339-45.
111. Bozzetti F. Effects of artificial nutrition on the nutritional status of cancer patients. J Parenter Enteral Nutr 1989;13(4):406-20.
112. Kinsella JE, Lokesh B. Dietary lipids, eicosanoids, and the immune system. Crit Care Med 1990;18:S94-S113.
113. Palmblad J. Lipid emulsions and host defense: critical review. Clin Nutr 1991;10:303-8.
114. Escudier EF, Escudier BJ, Henry AM, et al. Effects of infused intralipids on neutrophil chemotaxis during total parenteral nutrition. J Parenter Enteral Nutr 1986;10(6):596-8.
115. Klein S, Miles JM. Metabolic effects of long-chain and medium-chain triglyceride emulsions in humans [editorial; comment]. J Parenter Enteral Nutr 1994;18(5):396-7.
116. Lenssen P, Bruemmer B, Bowden R, et al. Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation. Am J Clin Nutr 1998;67:927-33.
117. Delafosse B, Viale JP, Pachiaudi C, et al. Long- and medium-chain triglycerides during parenteral nutrition in critically ill patients. Am J Physiol 1997;272:E550-5.
118. Goulet O, Postaire M, De PS, et al. Medium-chain triglycerides and long-term parenteral nutrition in children. Nutrition 1992;8(5):333-7.
119. von Ahsen N, Helmhold M, Schutz E, Eisenhauer T, Armstrong VW, Oellerich M. Cyclosporin A trough levels correlate with serum lipoproteins and apolipoproteins: implications for therapeutic drug monitoring of cyclosporin A. Ther Drug Monit 1997;19(2):140-5.
120. Wolters U, Keller HW, Becker R, Stickeler P, Dahlmeyer M, Muller JM. Influence of various fatty acids on tumour growth in total parenteral nutrition. Eur Surg Res 1994;26(5):288-97.
121. Rose DP. Dietary fatty acids and cancer. Am J Clin Nutr 1997;66(4):998S-1003S.
122. Bozzetti F. Nutritional support of the adult cancer patient. Clin Nutr 1992;11:167-79.
123. Cheney CL, Abson KG, Aker SN, et al. Body composition changes in marrow transplant recipients receiving total parenteral nutrition. Cancer 1987;59(8):1515-9.
124. Dressler C, Jeevanandam M, Brennan M. Metabolic efficacity of enteral feeding in malnourished cancer and non cancer patients. Metabolism 1987;36:82-8.
125. American, Gastroenterological, Association. Medical Position Statement: guidelines for the use of enteral nutrition. Gastroenterology 1995;108(4):1280-1.
126. Jolliet P, Pichard C, Biolo G, et al. Enteral nutrition in intensive care patients: a practical approach: working group on nutrition and metabolism, ESICM - European Society of Intensive Care Medicine. Intensive Care Med 1998;24(8):848-59.
127. Mercadante S. Parenteral versus enteral nutrition in cancer patients: indications and practice. Support Care Cancer 1998;6(2):85-93.
128. Hill AD, Daly JM. Current indications for intravenous nutritional support in oncology patients. Surg Oncol Clin North Am 1995;4(3):549-63.
129. Deitch EA. Bacterial translocation: the influence of dietary variables, Gut 1994;35(suppl. 1):S23-7.
130. Lipman TO. Grains or veins: is enteral nutrition really better than parenteral nutrition?, a look at the evidence. J Parenter Enteral Nutr 1998;22(3):167-82.
131. Corda B, Giudicelli A, Lagneau F, et al. Nutritional status: assessment during preoperative anaesthesia consultation (abstract). Intensive Care Med 1998;24(1):87.
132. Nitenberg G, Henry amar M, Escudier B, et al. Nutritional and immunological assessment in eso gastric cancer is predictive of tumoral extension, not of post operative complications. Clin Nutr 1984;4:34.
133. Fourtanier G, Prevost F, Lacaine F, Belghiti J, Hay JM. Nutritional status of patients with digestive system cancer: preoperative prognostic significance. Gastroenterol Clin Biol 1987;11(11):748-52.
134. Veterans ATPNCSG. Perioperative total parenteral nutrition in surgical patients, N Engl J Med 1991;325:525-532.
135. von Meyenfeldt M, Meijerink W, Rouflart M, Buil-Maasen M, Soeters P. Perioperative nutritional support: a randomised clinical trial. Clin Nutr 1992;11:180-6.
136. Heys SD, Gough DB, Eremin O. Is nutritional support in patients with cancer undergoing surgery beneficial? Eur J Surg Oncol 1996;22(3):292-7.
137. Anonymous. Conférence de Consensus. Nutrition artificielle périopératoire en chirurgie programmée de l'adulte. Nutr. Clin. Métabol. 1995;9(1):1-148.
138. Klein S, Kinney J, Jeejeebhoy K, et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions - Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr 1997;66(3):683-706.
139. Starker PM, LaSala PA, Askanazi J, Todd G, Hensle TW, Kinney JM. The influence of preoperative total parenteral nutrition upon morbidity and mortality. Surg Gynecol Obstet 1986;162(6):569-74.
140. Tandonnet F, Nitenberg G, Henry Amar M, Elias D, Escudier B, Leclercq B. Immediate post operative enteral versus parenteral nutrition in esogastric surgery for cancer: a controlled prospective study. Clin Nutr 1985;4:82.
141. Ziegler F, Nitenberg G, Coudray-Lucas C, Lasser P, Giboudeau J, Cynober L. Pharmacokinetic assessment of an oligopeptide-based enteral formula in abdominal surgery patients. Am J Clin Nutr 1998;67(1):124-8.
142. McClave SA, Snider HL, Spain DA. Preoperative issues in clinical nutrition. Chest 1999;115(5):64S-70S.
143. Braga M, Gianotti L, Radaelli G, et al. Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg 1999;134(4):428-33.
144. Heys SD, Walker LG, Smith I, Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 1999;229(4):467-77.
145. Senkal M, Mumme A, Eickhoff U, et al. Early postoperative enteral immunonutrition: clinical outcome and cost- comparison analysis in surgical patients. Crit Care Med 1997;25(9):1489-96.
146. American College of Physicians. Parenteral nutrition in patients receiving cancer chemotherapy, Ann. Intern. Med. 1989;110:734-736.
147. McGeer AJ, Detsky AS, O'Rourke K Parenteral nutrition in cancer patients undergoing chemotherapy: a meta-analysis. Nutrition 1990;6(3):233-40.
148. Klein S, Koretz R. Nutritional support in patients with cancer: what do the data really show? Nutr Clin Pract 1994;9:91-100.
149. Weisdorf S, Schwarzenberg S. Nutritional support of bone marrow transplantation recipient. In: Forman JFBK, Thomas ED, editors. Bone marrow transplantation. Boston: Blackwell, 1994:327-36.
150. Weisdorf SA, Lysne J, Wind D, et al. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation 1987;43(6):833-8.
151. Yokoyama S, Fuyimoto T, Mitomi T. Use of parenteral nutrition in pediatric bone marrow transplantation. Nutrition 1989;5:27-30.
152. Muscaritoli M, Conversano L, Torelli G, et al. Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation. Transplantation 1998;66:610-6.
153. Souba W. Nutritional support. N Engl J Med 1997;336:41-8.
154. Ziegler TR, Bye RL, Persinger RL, Young LS, Antin JH, Wilmore DW. Effects of glutamine supplementation on circulating lymphocytes after bone marrow transplantation: a pilot study. Am J Med Sci 1998;315(1):4-10.
155. Schloerb PR, Amare M. Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study). J Parenter Enteral Nutr 1993;17(5):407-13.
156. Scheltinga MR, Young LS, Benfell K, et al. Glutamine-enriched intravenous feedings attenuate extracellular fluid expansion after a standard stress. Ann Surg 1991;214(4):385-93.
157. Ziegler TR, Young LS, Benfell K. Clinical and metabolic efficacity of glutamine-supplemented parenteral nutrition after bone-marrow transplantation: a randomized, double-blind, controlled study. Ann Int Med 1992;116:821-8.
158. Anderson PM, Ramsay NK, Shu XO, et al. Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transpl 1998;22(4):339-44.
159. Schloerb P, Skikne B. Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blinded study. J Parenter Enteral Nutr 1999;23:117-22.
160. Canovas G, Leon-Sanz M, Sorni I, et al. Efficacy of glutamine vs. whole protein supplements on gastrointestinal toxicity of high dose chemotherapy in autologous hemopoietic transplant. Clin Nutr 1997;16(2):41.
161. Charuhas PM, Fosberg KL, Bruemmer B, et al. A double-blind randomized trial comparing outpatient parenteral nutrition with intravenous hydration: effect on resumption of oral intake after marrow transplantation. J Parenter Enteral Nutr 1997;21(3):157-61.
162. Ribaud P, Socié G, Parquet N, et al. Prise en charge nutritionnelle des malades allogreffés de moelle. Nutr Clin Métabol 1997;11:401-4.
163. Mulder P, Bouman J, Gietema J, et al. Hyperalimentation in autologous bone marrow transplantation in solid tumors. Cancer 1989;64:2045-52.
164. Szeluga DJ, Stuart RK, Brookmeyer R, Utermohlen V, Santos GW. Nutritional support of bone marrow transplant recipients: a prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res 1987;47(12):3309-16.
165. Papadopoulou A, MacDonald A, Williams MD, Darbyshire PJ, Booth IW. Enteral nutrition after bone marrow transplantation. Arch Dis Childhood 1997;77(2):131-6.
166. Roberts S, Miller J. Success using PEG tubes in marrow transplant recipients. Nutr Clin Pract 1998;13:74-8.
167. Papadopoulou A, Williams MD, Darbyshire PJ, Booth IW. Nutritional support in children undergoing bone marrow transplantation. Clin Nutr 1998;17(2):57-63.
168. Chlebowski RT. Nutritional support of radiotherapy in oropharyngeal cancer. Nutrition 1992;8(1):54.
169. Fietkau R. Principles of feeding cancer patients via enteral or parenteral nutrition during radiotherapy. Strahlenther Onkol 1998;174(Suppl 3):47-51.
170. Donaldson SS. Nutritional support as an adjunct to radiation therapy. J Parenter Enteral Nutr 1984;8(3):302-10.
171. Goodwin WJ, Byers PM. Nutritional management of the head and neck cancer patient. Med Clin North Am 1993;77(3):597-610.
172. Lopez MJ, Robinson P, Madden T, Highbarger T. Nutritional support and prognosis in patients with head and neck cancer. J Surg Oncol 1994;55(1):33-6.
173. Cozzaglio L, Balzola F, Cosentino F, et al. Outcome of cancer patients receiving home parenteral nutrition: Italian Society of Parenteral and Enteral Nutrition (SINPE). J Parenter Enteral Nutr 1997;21(6):339-42.
174. Howard L, Ament M, Fleming C, et al. Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology 1995;109:355-65.
175. Barber MD, Fearon KC, Delmore G, Loprinzi CL. Should cancer patients with incurable disease receive parenteral or enteral nutritional support? Eur J Cancer 1998;34(3):279-85.
176. Ireton-Jones C, Orr M, Hennessy K. Clinical pathways in home nutrition support. J Am Diet Assoc 1997;97(9):1003-7.
177. Steiner N, Bruera E. Methods of hydration in palliative care patients. J Palliat Care 1998;14(2):6-13.
178. Frank J, Lawrence W, Banks WL, McKinnon WJG, Chan WM, Collins JM. Modulation of cell cycle kinetics in human cancer with total parenteral nutrition, Cancer 1992;69:1858-64.
179. Torosian MH. Stimulation of tumor growth by nutrition support. J Parenter Enteral Nutr 1992;16(6):72S-5S.
180. Hulsewe KW, van Acker BA, von Meyenfeldt MF, Soeters PB. Nutritional depletion and dietary manipulation: effects on the immune response. World J Surg 1999;23(6):536-44.
181. Sasamura T, Matsuda A, Kokuba Y. Nutritional effects of a D-methionine-containing solution on AH109A hepatoma-bearing rats. Biosci Biotech Biochem 1998;62(12):2418-20.
182. Dechelotte P. Pharmacological nutritionand immune nutrition in cancer patients. In: Cynober L, Fürst P, Lawin P, editors. Pharmacological nutrition, Immune nutrition. New York: Verlag, 1995:122-34.
183. Imoberdorf R. Immuno-nutrition: designer diets in cancer. Support Care Cancer 1997;5(5):381-6.
184. Wilmore DW, Shabert JK. Role of glutamine in immunologic responses. Nutrition 1998;14:618-26.
185. Holm E, Hagmuller E, Staedt U, et al. Substrate balances across colonic carcinomas in humans. Cancer Res 1995;55(6):1373-8.
186. Abumrad NN, Kim S, Molina PE. Regulation of gut glutamine metabolism: role of hormones and cytokines. Proceed Nutr Soc 1995;54(2):525-33.
187. Austgen TR, Chen MK, Dudrick PS, Copeland EM, Souba WW. Cytokine regulation of intestinal glutamine utilization. Am J Surg 1992;163(1):174-9.
188. Soeters PB, de Blaauw I, van Acker BA, von Meyenfeldt MF, Deutz NE. In vivo inter-organ protein metabolism of the splanchnic region and muscle during trauma, cancer and enteral nutrition. Baillieres Clin Endocrinol Metabol 1997;11(4):659-77.
189. Hidalgo M, Rodriguez G, Kuhn JG, et al. A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies. Clin Cancer Res 1998;4(11):2763-70.
190. Newsholme EA. The possible role of glutamine in some cells of the immune system and the possible consequence for the whole animal. Experientia 1996;52(5):455-9.
191. Van der Hulst RR, Von Meyenfeldt MF, Tiebosch A, Buurman WA, Soeters PB. Glutamine and intestinal immune cells in humans. J Parenter Enteral Nutr 1997;21(6):310-5.
192. Klimberg V, Mc Clellan J. Glutamine, cancer, and its therapy. Am J Surg 1996;172:418-24.
193. O'Riordain MG, De Beaux A, Fearon KC. Effect of glutamine on immune function in the surgical patient. Nutrition 1996;12(11-12):S82-4.
194. Heubi JE. Whenever possible, use the gut: [comment]. J Pediatr Hematol Oncol 1999;21(2):88-90.
195. Jebb SA, Osborne RJ, Maughan TS, et al. 5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation. Br J Cancer 1994;70(4):732-5.
196. Skubitz KM, Anderson PM. Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study. J Lab Clin Med 1996;127(2):223-8.
197. Savarese D, Boucher J, Corey B. Glutamine treatment of paclitaxel-induced myalgias and arthralgias. J Clin Oncol 1998;16(12):3918-9.
198. MacBurney M, Young L, Ziegler T, Wilmore D. A cost-evaluation of glutamine-supplemented parenteral nutrition in adult bone marrow transplant patients. J Am Diet Assoc 1994;94(11):1263-6.
199. Van Zaanen HCT, Van der Lelie H, Timmer JG, Fürst P, Sauerwein HP. Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity. Cancer 1994;74:2879-84.
200. Bozzetti F, Biganzoli L, Gavazzi C, et al. Glutamine supplementation in cancer patients receiving chemotherapy: a double-blind randomized study. Nutrition 1997;13(7-8):748-51.
201. Le Boucher J, Cynober LA. Ornithine alpha-ketoglutarate: the puzzle. Nutrition 1998;14(11-12):870-3.
202. Cynober LA. Ornithine α-ketoglutarate. In: Cynober LA, ed. Amino acid metabolism and therapy in health and nutritional diseases. Boca Raton: CRC Press, 1995:385-398.
203. Blomqvist BI, Hammarqvist F, von der Decken A, Wernerman J. Glutamine and alpha-ketoglutarate prevent the decrease in muscle free glutamine concentration and influence protein synthesis after total hip replacement. Metab Clin Exp 1995;44(9):1215-22.
204. Donati L, Ziegler F, Pongelli G, Signorini M. Nutritional and clinical efficacy of ornithine alpha-ketoglutarate in severe burn patients. Clin Nutr 1999;18:307-12.
205. Le Bricon T, Cynober L, Field CJ, Baracos VE. Supplemental nutrition with ornithine alpha-ketoglutarate in rats with cancer-associated cachexia: surgical treatment of the tumor improves efficacy of nutritional support. J Nutr 1995;125(12):2999-3010.
206. Evoy D, Lieberman M, Fahey T, Daly J. Immunonutrition: the role of arginine. Nutrition 1998;14:611-7.
207. Kirk SJ, Barbul A. Role of arginine in trauma, sepsis, and immunity, J Parenter Enteral Nutr 1990;14:226S-9S.
208. Barbul A. Arginine: Biochemistry, physiology, and therapeutic implications. J Parenter Enteral Nutr 1986;10:227-38.
209. Alexander JW, Ogle CK, Nelson JL. Diets and infection: composition and consequences. World J Surg 1998;22(2):209-12.
210. Rodeberg DA, Chaet MS, Bass RC, Arkovitz MS, Garcia VF. Nitric oxide: an overview. Am J Surg 1995;170(3):292-303.
211. Park KG, Keys SD, Blessing K, et al. Stimulation of human breast cancers by dietary L-arginine. Clin Sci (Colch) 1992;82(4):413-7.
212. Brittenden J, Park KG, Keys SD, et al. L-arginine stimulates host defenses in patients with breast cancer. Surgery 1994;115(2):205-12.
213. Caso G, Matar S, McNurlan M, McMillan D, Eremin O, Garlick P. Metabolic effects of arginine on malignant tissues. Clin Nutr 1996;15:89-90.
214. Alexander JW. Immunonutrition: the role of omega-3 fatty acids. Nutrition 1998;14:627-33.
215. Pomposelli JJ, Flores EA, Blackburn GL, Zeisel SH, Bistrian BR. Diets enriched with N-3 fatty acids ameliorate lactic acidosis by improving endotoxin-induced tissue hypoperfusion in guinea pigs. Ann Surg 1991;213(2):166-76.
216. Karmali RA. Historical perspective and potential use of n-3 fatty acids in therapy of cancer cachexia. Nutrition 1996;12(1):S2-4.
217. Tisdale MJ. Mechanism of lipid mobilization associated with cancer cachexia: interaction between the polyunsaturated fatty acid, eicosapentaenoic acid, and inhibitory guanine nucleotide-regulatory protein. Prostagl Leukotr Essent Fatty Acids 1993;48(1):105-9.
218. Latham P, Lund EK, Johnson IT. Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon. Carcinogenesis 1999;20(4):645-50.
219. Wigmore SJ, Ross JA, Falconer JS, et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 1996;12(1):S27-30.
220. Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KC. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 1999;81(1):80-6.
221. Bartlett DL, Charland S, Torosian MH. Growth hormone, insulin, and somatostatin therapy of cancer cachexia. Cancer 1994;73(5):1499-504.
222. Wolf RF, Pearlstone DB, Newman E, et al. Growth hormone and insulin reverse net whole body and skeletal muscle protein catabolism in cancer patients. Ann Surg 1992;216(3):280-8.
223. Berman RS, Harrison LE, Pearlstone DB, Burt M, Brennan MF. Growth hormone, alone and in combination with insulin, increases whole body and skeletal muscle protein kinetics in cancer patients after surgery. Ann Surg 1999;229(1):1-10.
224. Carbo N, Lopez-Soriano J, Tarrago T, et al. Comparative effects of beta2-adrenergic agonists on muscle waste associated with tumour growth. Cancer Lett 1997;115(1):113-8.
225. Braga M, Gianotti L, Cestari A, et al. Gut function and immune and inflammatory rasponses in patients perioperatively fed with supplemented enteral formulas. Arch Surg 1996;131:1257-65.
226. Kemen M, Senkal M, Homann H, et al. Early postoperative enteral nutrition with arginine, omega-3 fatty acids and ribonu-cleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of impact. Crit Care Med 1995;23:652-9.
227. Wachtler P, Konig W, Senkal M, Kemen M, Koller M. Influence of a total parenteral nutrition enriched with omega-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. J Trauma 1997;42(2):191-8.
228. Daly JM, Lieberman MD, Goldfine J, et al. Enterai nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 1992;112(1):56-67.
229. Daly JM, Weintraub FN, Shou J, Rosato EF, Lucia M. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 1995;221(4):327-38.
230. Heslin MJ, Latkany L, Leung D, et al. A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. Ann Surg 1997;226(4):567-77.
231. Braga M, Gianotti L, Vignali A, Cestari APB, Di Carlo V. Artificial nutrition after major abdominal surgery: impact of route of administration and composition of the diet. Crit Care Med 1998;26(1):24-30.
232. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999;281(20):1900-5.
233. Kant AK. Indexes of overall diet quality: a review. J Am Diet Assoc 1996;96(8):785-91.
234. Margetts BM, Thompson RL, Key T, et al. Development of a scoring system to judge the scientific quality of information from case-control and cohort studies of nutrition and disease. Nutr Cancer 1995;24(3):231-9.
235. Van Eys J. Benefits of nutritional intervention on nutritional status, quality of life and survival. Int J Cancer 1998;11:66-8.
236. Kenler AS, Swails WS, Driscoll DF, et al. Early enteral feeding in postsurgical cancer patients: fish oil structured lipid-based polymeric formula versus a standard polymeric formula. Ann Surg 1996;223(3):316-33.
237. Schilling J, Vranjes N, Fierz W, et al. Clinical outcome and immunology of postoperative arginine, omega-3 fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat i.v. solutions. Nutrition 1996;12(6):423-9.
238. Snyderman CH, Kachman K, Molseed L, et al. Reduced post-operative infections with an immune-enhancing nutritional supplement. Laryngoscope 1999;109(6):915-21.